The study also revealed that SCA exerted its protective effects by activating the PI3K-AKT/Nrf2/ARE pathway and suppressing the TLR4/MAPK/NF-κB pathways. The gene discussed is NFE2L2; the disease is autosomal dominant cerebellar ataxia.